Cargando…
Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development?
Autor principal: | Vaillant, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227515/ https://www.ncbi.nlm.nih.gov/pubmed/35746664 http://dx.doi.org/10.3390/v14061193 |
Ejemplares similares
-
Subviral Agents
por: STRAUSS, JAMES H., et al.
Publicado: (2008) -
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020) -
CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016) -
Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
por: Gomez-Escobar, Elsa, et al.
Publicado: (2021) -
Molecular targeted agents—where we are and where we are going
por: Yan, Li
Publicado: (2013)